HCP Education - Teva supports healthcare professionals, patients, and caregivers through independent education to strengthen clinical decisions and improve health behaviors or health status.
Patient Education - Teva supports organizations that educate people with Huntington’s disease, tardive dyskinesia, or schizophrenia and their caregivers to improve understanding of symptoms, management, and treatment.
Schizophrenia – HCP supports educational providers delivering independent healthcare professional education on antipsychotics and long-acting injectables to improve treatment competence and prevent relapse.
Tardive Dyskinesia - HCP supports healthcare professionals through independent medical education to improve recognition, diagnosis, assessment, and management of TD, including VMAT2 inhibitor use.
The HD Human Experience Project from the Huntington's Disease Society of America funds research on the lived experience and non-motor symptoms of Huntington's disease, focusing on patient-centered outcomes.